Thoreau in its investment in Ensemble, a provider of revenue cycle managed services.
Apogee Therapeutics (Nasdaq: APGE), a clinical-stage biotechnology company, in its pending $10.9 billion sale to AbbVie (NYSE: ABBV).
Eli Lilly and Company (NYSE: LLY) in its pending $7 billion acquisition of Kelonia Therapeutics, a clinical-stage biotechnology company.
Kingswood Capital Management in its acquisition of Drive DeVilbiss Healthcare, a manufacturer and supplier of medical products, from CD&R.
Avidity Biosciences, a biopharmaceutical company, in its pending $12 billion sale to Novartis.
Bain Capital in its acquisition of HealthEdge, a provider of healthcare technology solutions, from Blackstone.
Bansk Group in its acquisition of BYOMA, a provider of a skincare brand, from Yellow Wood Partners.
Blue Sea Capital in its acquisition of MicroCare, a provider of precision cleaning, coating and lubrication solutions for mission-critical applications.
Francisco Partners in its sale of Orchard Software, a provider of laboratory information systems, to Clinisys.
Olympus Partners in its acquisition of PAI Pharma, a provider of generic oral liquid medicines.
Thoma Bravo-backed Bluesight in its acquisition of Protenus, a developer of a healthcare compliance analytics platform.
Francisco Partners and TA Associates-backed Edifecs, a provider of healthcare information systems management software, in its sale to Cotiviti.
